HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

被引：0
|
作者：
Young, Guy
Sidonio, Robert F.
Liesner, Ri
Oldenburg, Johannes
Chang, Tiffany
Uguen, Marianne
Dhalluin, Christophe
Schmitt, Christophe
Levy, Gallia G.
Shima, Midori
Mahlangu, Johnny
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页数：4
相关论文
共 50 条
  • [1] HAVEN 2 Updated Analysis: Multicentre, Open-label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Paediatric Patients with Haemophilia A with Inhibitors
    Young, G.
    Sidonio, R. F.
    Liesner, R.
    Oldenburg, J.
    Chang, T.
    Uguen, M.
    Dhalluin, C.
    Schmitt, C.
    Levy, G. G.
    Shima, M.
    Mahlangu, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 20 - 21
  • [2] A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
    Young, Guy
    Liesner, Ri
    Chang, Tiffany
    Sidonio, Robert, Jr.
    Oldenburg, Johannes
    Jimenez-Yuste, Victor
    Mahlangu, Johnny
    Kruse-Jarres, Rebecca
    Wang, Michael
    Uguen, Marianne
    Doral, Michelle Y.
    Wright, Lilyan Y.
    Schmitt, Christophe
    Levy, Gallia G.
    Shima, Midori
    Mancuso, Maria Elisa
    BLOOD, 2019, 134 (24) : 2127 - 2138
  • [3] Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)
    Kruse-Jarres, Rebecca
    Callaghan, Michael U.
    Croteau, Stacy E.
    Jimenez-Yuste, Victor
    Khoo, Liane
    Liesner, Ri
    Matsushita, Tadashi
    Recht, Michael
    Young, Guy
    Chang, Tiffany
    Dhalluin, Christophe
    Mu, Yunming
    Xu, Jin
    Devenport, Jenny
    Ko, Richard H.
    Solari, Paul
    Oldenburg, Johannes
    BLOOD, 2017, 130
  • [4] A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A
    Shima, Midori
    Amano, Kagehiro
    Ogawa, Yoshiyuki
    Yoneyama, Koichiro
    Ozaki, Ryoto
    Kobayashi, Ryota
    Sakaida, Emiko
    Saito, Makoto
    Okamura, Takashi
    Ito, Toshihiro
    Hattori, Norimichi
    Higasa, Satoshi
    Suzuki, Nobuaki
    Seki, Yoshinobu
    Nogami, Keiji
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (03) : 534 - 545
  • [5] Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial
    Pipe, Steven W.
    Collins, Peter
    Dhalluin, Christophe
    Kenet, Gili
    Schmitt, Christophe
    Buri, Muriel
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Young, Guy
    Oldenburg, Johannes
    Mancuso, Maria Elisa
    Kavakli, Kaan
    Kiialainen, Anna
    Deb, Sonia
    Niggli, Markus
    Chang, Tiffany
    Lehle, Michaela
    Fijnvandraat, Karin
    BLOOD, 2024, 143 (14) : 1355 - 1364
  • [6] Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
    Pipe, Steven W.
    Shima, Midori
    Lehle, Michaela
    Shapiro, Amy
    Chebon, Sammy
    Fukutake, Katsuyuki
    Key, Nigel S.
    Portron, Agnes
    Schmitt, Christophe
    Podolak-Dawidziak, Maria
    Bienz, Nives Selak
    Hermans, Cedric
    Campinha-Bacote, Avrita
    Kiialainen, Anna
    Peerlinck, Kathelijne
    Levy, Gallia G.
    Jimenez-Yuste, Victor
    LANCET HAEMATOLOGY, 2019, 6 (06): : E295 - E305
  • [7] A Phase IV, Multicenter, Open-Label Study of Emicizumab Prophylaxis in Persons with Hemophilia a with or without FVIII Inhibitors Undergoing Minor Surgical Procedures
    Escobar, Miguel A.
    Dunn, Amy
    Quon, Doris
    Trzaskoma, Ben
    Lee, Lucy
    Ko, Richard H.
    Carpenter, Shannon L.
    BLOOD, 2020, 136
  • [8] A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis
    Hyarns, Jeffrey S.
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Sabra
    Cohen, Stanley A.
    Markowitz, James
    Veereman, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne M.
    GASTROENTEROLOGY, 2011, 140 (05) : S124 - S125
  • [9] Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
    Enya, Kazuaki
    Saji, Ben T.
    Kato, Takuya
    Okamoto, Hiroyuki
    Koumura, Emiko
    ADVANCES IN THERAPY, 2018, 35 (08) : 1181 - 1190
  • [10] Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
    Kazuaki Enya
    Ben T. Saji
    Takuya Kato
    Hiroyuki Okamoto
    Emiko Koumura
    Advances in Therapy, 2018, 35 : 1181 - 1190
12345